SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001837607-24-000042
Filing Date
2024-04-29
Accepted
2024-04-29 16:25:45
Documents
4
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A aeon-20240614xdef14a.htm DEF 14A 943283
2 GRAPHIC aeon-20240614xdef14a_a002.jpg GRAPHIC 12224
3 GRAPHIC aeon-20240614xdef14a_bg001.jpg GRAPHIC 136523
4 GRAPHIC aeon-20240614xdef14a_bg002.jpg GRAPHIC 102900
  Complete submission text file 0001837607-24-000042.txt   1291425
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40021 | Film No.: 24891316
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)